Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium
Health Policy, 06/13/08
Neyt M et al. - The model shows better cost-effectiveness for the 9-week initial treatment (FinHer) compared to no trastuzumab treatment than for the 1-year post-chemotherapy treatment (HERA). Both from a medical and an economic point of view, the 9-week initial treatment regimen with trastuzumab shows promising results and justifies the initiation of a large comparative trial with a 1-year regimen.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09
Relevance Score: 74%
Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
British Journal of Cancer, 11/30/09
Relevance Score: 72%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 71%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 71%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced chemo-fog
Journal of Clinical Pharmacy and Therapeutics, 03/11/10
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Cancer Letters, 03/10/10
Role of Basic Residues Within or Near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein in Drug Transport
Journal of Pharmacology and Experimental Therapeutics, 03/10/10
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-Effectiveness Analysis of Short-Term Clopidogrel Therapy for ST Elevation Myocardial Infarction
Critical Pathways in Cardiology, 03/11/10
Estimating the Cost of Health Care-Associated Infections: Mind Your p's and q's
Clinical Infectious Diseases, 03/08/10
Costs of Gastrointestinal Events After Outpatient Opioid Treatment for Non-Cancer Pain
Annals of Pharmacotherapy, 03/03/10
Article Search
Sponsor
Sponsor


See Latest Articles


